Urinary miR-142-3p: a novel biomarker of the progression of IgA nephropathy.
Saved in:
| Title: | Urinary miR-142-3p: a novel biomarker of the progression of IgA nephropathy. |
|---|---|
| Authors: | Duan ZY; Department of Nephrology, First Medical Center of Chinese People's Liberation Army (PLA) General Hospital, National Key Laboratory of Kidney Diseases, National Clinical Research Center for Kidney Diseases, Beijing Key Laboratory of Kidney Diseases Research, Beijing, China., Zhang M; Department of Nephrology, First Medical Center of Chinese People's Liberation Army (PLA) General Hospital, National Key Laboratory of Kidney Diseases, National Clinical Research Center for Kidney Diseases, Beijing Key Laboratory of Kidney Diseases Research, Beijing, China., Bu R; Department of Nephrology, First Medical Center of Chinese People's Liberation Army (PLA) General Hospital, National Key Laboratory of Kidney Diseases, National Clinical Research Center for Kidney Diseases, Beijing Key Laboratory of Kidney Diseases Research, Beijing, China., Zhang QY; Department of Nephrology, First Medical Center of Chinese People's Liberation Army (PLA) General Hospital, National Key Laboratory of Kidney Diseases, National Clinical Research Center for Kidney Diseases, Beijing Key Laboratory of Kidney Diseases Research, Beijing, China., Wu J; Department of Nephrology, First Medical Center of Chinese People's Liberation Army (PLA) General Hospital, National Key Laboratory of Kidney Diseases, National Clinical Research Center for Kidney Diseases, Beijing Key Laboratory of Kidney Diseases Research, Beijing, China., Duan S; Department of Nephrology, First Medical Center of Chinese People's Liberation Army (PLA) General Hospital, National Key Laboratory of Kidney Diseases, National Clinical Research Center for Kidney Diseases, Beijing Key Laboratory of Kidney Diseases Research, Beijing, China., Lin S; Department of Nephrology, First Medical Center of Chinese People's Liberation Army (PLA) General Hospital, National Key Laboratory of Kidney Diseases, National Clinical Research Center for Kidney Diseases, Beijing Key Laboratory of Kidney Diseases Research, Beijing, China., Chen XZ; Department of Nephrology, First Medical Center of Chinese People's Liberation Army (PLA) General Hospital, National Key Laboratory of Kidney Diseases, National Clinical Research Center for Kidney Diseases, Beijing Key Laboratory of Kidney Diseases Research, Beijing, China., Wang W; Department of Nephrology, First Medical Center of Chinese People's Liberation Army (PLA) General Hospital, National Key Laboratory of Kidney Diseases, National Clinical Research Center for Kidney Diseases, Beijing Key Laboratory of Kidney Diseases Research, Beijing, China., Chen XM; Department of Nephrology, First Medical Center of Chinese People's Liberation Army (PLA) General Hospital, National Key Laboratory of Kidney Diseases, National Clinical Research Center for Kidney Diseases, Beijing Key Laboratory of Kidney Diseases Research, Beijing, China., Feng Z; Department of Nephrology, First Medical Center of Chinese People's Liberation Army (PLA) General Hospital, National Key Laboratory of Kidney Diseases, National Clinical Research Center for Kidney Diseases, Beijing Key Laboratory of Kidney Diseases Research, Beijing, China., Cai GY; Department of Nephrology, First Medical Center of Chinese People's Liberation Army (PLA) General Hospital, National Key Laboratory of Kidney Diseases, National Clinical Research Center for Kidney Diseases, Beijing Key Laboratory of Kidney Diseases Research, Beijing, China. |
| Source: | Frontiers in immunology [Front Immunol] 2026 May 11; Vol. 17, pp. 1715735. Date of Electronic Publication: 2026 May 11 (Print Publication: 2026). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
